GB1381031A - Imidazole derivatives and processes for their production - Google Patents

Imidazole derivatives and processes for their production

Info

Publication number
GB1381031A
GB1381031A GB1978172A GB1978172A GB1381031A GB 1381031 A GB1381031 A GB 1381031A GB 1978172 A GB1978172 A GB 1978172A GB 1978172 A GB1978172 A GB 1978172A GB 1381031 A GB1381031 A GB 1381031A
Authority
GB
United Kingdom
Prior art keywords
prepared
reacting
phenyl
ketone
ammonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1978172A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH687571A external-priority patent/CH554415A/en
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1381031A publication Critical patent/GB1381031A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Abstract

1381031 Phenyl-heteroaromatic substituted imidazole derivatives CIBA-GEIGY AG 28 April 1972 [11 May 1971 22 March 1972] 19781/72 Heading C2C Novel compounds of the Formula I wherein R 1 is C 1-6 alkyl, cycloalkyl or phenyl which is optionally substituted by one or more halogen or C 1-6 alkyl or alkoxy substituents and one of the groups R 2 and R 3 is phenyl optionally substituted by one or more halogen, hydroxy or C 1-6 alkyl, alkoxy, alkylthio or alkylsulphonyl substituents and the other represents a 6-membered heteroaromatic radical containing 1 or 2 ring nitrogen atoms, and N- oxides and salts thereof may be prepared by (a) reacting a diketone II or a mono-oxime or N-oxide thereof with ammonia and an aldehyde R 1 .CHO; (b) reacting an amide V with ammonia; (c) reacting a reactive ester of IIa with an amidine R 1 C(:NH)NH 2 or a salt thereof; (d) reacting an oxazole VII with ammonia and optionally forming an N- oxide or converting an N-oxide to a free compound and/or optionally forming a salt or converting a salt to a free base. The intermediate diketones II may be prepared by oxidation of the monoketones R 2 COCH 2 R 3 or R 2 CH 2 COR 3 , or the olefin R 2 C : CR 3 . The intermediate benzyl pyridyl ketones may be prepared by reaction of a pyridine carboxylic ester with a phenylacetic acid ester in the presence of strong base. Phenyl - (pyrazinyl - 2 - methyl) - ketone may be prepared by reaction of 2-methyl pyrazine with sodamide followed by methyl benzoate. (α - Hydroxyimino - benzyl) - (3 - pyridyl)- ketone may be prepared by reaction of benzyl-(3- pyridyl)-ketone with nitrous acid followed by basicification. Pharmaceutical compositions of the compounds I show anti-inflammatory, antipyretic, antiphlogistic and analgesic activity when administered orally, rectally, parenterally or topically with the usual excipients.
GB1978172A 1971-05-10 1972-04-28 Imidazole derivatives and processes for their production Expired GB1381031A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH687571A CH554415A (en) 1970-06-01 1971-05-10 PROCESS FOR THE PRODUCTION OF LEMONIC ACID BY SUBMERSE FERMENTATION.
CH696771A CH561202A5 (en) 1971-05-10 1971-05-11
CH697571 1971-05-12
CH425072A CH579072A5 (en) 1971-05-10 1972-03-22

Publications (1)

Publication Number Publication Date
GB1381031A true GB1381031A (en) 1975-01-22

Family

ID=27428754

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1978172A Expired GB1381031A (en) 1971-05-10 1972-04-28 Imidazole derivatives and processes for their production

Country Status (10)

Country Link
AT (4) AT319939B (en)
AU (1) AU472065B2 (en)
BE (1) BE783244A (en)
CA (1) CA1012148A (en)
CH (5) CH561716A5 (en)
DE (1) DE2221546A1 (en)
FR (1) FR2137740B1 (en)
GB (1) GB1381031A (en)
NL (1) NL7206346A (en)
SE (1) SE405731B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032113A2 (en) * 1980-01-07 1981-07-15 E.I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1H-imidazole-2-methanols
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
WO2000061576A1 (en) * 1999-04-09 2000-10-19 Smithkline Beecham Corporation Triarylimidazoles
WO2001072737A1 (en) * 2000-03-27 2001-10-04 Smithkline Beecham Corporation Triarylimidazole derivatives as cytokine inhibitors

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75287B (en) * 1980-07-25 1984-07-13 Ciba Geigy Ag
WO1983002613A1 (en) * 1981-07-20 1983-08-04 Sallmann, Alfred Trisubstituted oxazo compounds
AU554104B2 (en) * 1981-09-01 1986-08-07 F. Hoffmann-La Roche Ag Heterocyclic compounds and fungicides containing same
EP0084756A1 (en) * 1982-01-22 1983-08-03 Ciba-Geigy Ag Trisubstituted oxaza compounds
EP0084757A1 (en) * 1982-01-25 1983-08-03 Ciba-Geigy Ag Trisubstituted diaza derivatives
IL83467A0 (en) * 1986-08-15 1988-01-31 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
US5656644A (en) * 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
ES2053401B1 (en) * 1992-01-13 1995-03-01 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS AND PROCEDURES FOR ITS PREPARATION.
MX9300141A (en) * 1992-01-13 1994-07-29 Smithkline Beecham Corp NOVEL IMIDAZOLE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
DE69433501T2 (en) * 1993-11-08 2004-11-04 Smithkline Beecham Corp. OXAZOLES FOR TREATING CYTOKINE MEDIATED DISEASES
US6426360B1 (en) * 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
EP0797575B1 (en) * 1994-12-13 2003-10-15 F. Hoffmann-La Roche Ag Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
TW492959B (en) * 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
US6127545A (en) * 1997-04-18 2000-10-03 Merck & Co., Inc. Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
US6130334A (en) * 1998-04-15 2000-10-10 Merck & Co., Inc. Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors
AR029803A1 (en) * 2000-02-21 2003-07-16 Smithkline Beecham Plc IMIDAZOLS REPLACED WITH PIRIDILE AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192211A (en) * 1962-05-03 1965-06-29 Nl Combinatie Chem Ind 5-phenyl-5-(2-pyrazyl)-hydantoin
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032113A2 (en) * 1980-01-07 1981-07-15 E.I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1H-imidazole-2-methanols
EP0032113A3 (en) * 1980-01-07 1981-08-05 E.I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1h-imidazole-2-methanols
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols
US5620999A (en) * 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
EP1211244A2 (en) * 1994-07-28 2002-06-05 G.D. Searle & Co. 4,5-substitued imidazolyl compounds for the treatment of inflammation
EP1211244A3 (en) * 1994-07-28 2002-06-12 G.D. Searle & Co. 4,5-substitued imidazolyl compounds for the treatment of inflammation
WO2000061576A1 (en) * 1999-04-09 2000-10-19 Smithkline Beecham Corporation Triarylimidazoles
WO2001072737A1 (en) * 2000-03-27 2001-10-04 Smithkline Beecham Corporation Triarylimidazole derivatives as cytokine inhibitors
US6906089B2 (en) 2000-03-27 2005-06-14 Smithkline Beecham Corporation Triarylimidazole derivatives as cytokine inhibitors

Also Published As

Publication number Publication date
AU4205572A (en) 1973-11-15
CH579072A5 (en) 1976-08-31
CA1012148A (en) 1977-06-14
AT319940B (en) 1975-01-10
AU472065B2 (en) 1976-05-13
NL7206346A (en) 1972-11-14
AT316544B (en) 1974-07-10
SE405731B (en) 1978-12-27
FR2137740A1 (en) 1972-12-29
BE783244A (en) 1972-11-10
FR2137740B1 (en) 1975-08-01
CH561716A5 (en) 1975-05-15
AT319939B (en) 1975-01-10
CH561718A5 (en) 1975-05-15
DE2221546A1 (en) 1972-11-16
CH561717A5 (en) 1975-05-15
CH561202A5 (en) 1975-04-30
AT319941B (en) 1975-01-10

Similar Documents

Publication Publication Date Title
GB1381031A (en) Imidazole derivatives and processes for their production
GB1358680A (en) Pyrrolo-3,4-b-pyrazine derivatives
GB1351430A (en) Substituted 1,2,4-triazole derivatives
ES362861A1 (en) 2-methyl - 3 - carboxylic acid amido-quinoxaline-1 4-di-n-ozides and their production
GB1498509A (en) Alpha-benzylidene lactone derivatives
GB1384035A (en) Amino alkyl esters of 2-anilino nicotinic acid and their preparation
GB1273705A (en) A method for producing 3,5-diaryl-4-pyrazole acetic acids
ES358796A1 (en) 2-halomethyl-3-carboxylic acid amido-quinoxaline-1,4-di-n-oxides and their production
GB1173687A (en) Pyridyl-Tetrahydroisoquinolines
GB1489332A (en) Reduced bicyclic pyridone derivatives
GB1386664A (en) Aminothiophene-carboxylic acid esters and process for their preparation
GB1438419A (en) 2-oxo-1-pyridinyl penicillin and cephalosporin derivatives
GB1488778A (en) Salt of alpha-methyl-(5-benzoyl-2-thiophene)-acetic acid processes for preparing it and compositions containing it
GB1452203A (en) Pyrrole derivatives and process for their manufacture
GB1066886A (en) Imidazole derivatives
GB1425911A (en) Phenylacetic acid derivatives, process for their preparation and therapeutic composition containing same
GB1369888A (en) Substituted amidines
GB1286795A (en) New azomethines and their production
ES363480A1 (en) Derivatives of tetrazolyl alkanoic acids
GB1378608A (en) 5-indolyloxy- acetic acid derivatives
GB1422040A (en) Process for preparing ketones
SE7609497L (en) PROCEDURE FOR THE PREPARATION OF 2-HYDROXIMETHYL-3-HYDROXY-6- (1-HYDROXY-2-T-BUTYLAMINOETHYL) -PYRIDINE AND INTERMEDIATE PRODUCTS THEREOF
GB1327536A (en) Xanthen-2-yl-propionic acids
GB1295561A (en)
SE7609357L (en) METHOD OF PRODUCING 2,4,5-TRIMETHYL-TIENO / 3,2-F / -MORPHANE

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee